% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Offringa:302272,
author = {R. Offringa$^*$ and Z. B. Meng$^*$ and H. K. Cai and X. Y.
Shi and H. Mei and H. S. Wu},
title = {[{I}mplementation of personalized {T}-cell therapy in the
treatment of pancreatic cancer].},
journal = {Zhong hua wai ke za zhi},
volume = {63},
number = {8},
issn = {0529-5815},
address = {Bei jing shi},
publisher = {[Verlag nicht ermittelbar]},
reportid = {DKFZ-2025-01298},
pages = {666-671},
year = {2025},
note = {ISSN 0529-5815 / #EA:D200# / Article in Chinese},
abstract = {Pancreatic ductal adenocarcinoma is profoundly
treatment-resistant, due to intrinsic properties of the
tumor cells and the complex tumor microenvironment.
Consequently, surgical resection of the primary tumor is
still the only intervention that significantly prolongs
patient survival. This points at an urgent need for more
effective (neo)adjuvant strategies to increase the fraction
of patients eligible to surgery and to counter post-surgery
disease recurrence. The advent of single-cell RNA-sequencing
has created an opportunity for the development of a highly
potent, patient-tailored adjuvant treatment that is based on
the infusion of genetically engineered autologous T-cells
armed with tumor-reactive T-cell receptors as identified in
the patient's own tumor sample.},
subtyp = {Review Article},
cin = {D200},
ddc = {610},
cid = {I:(DE-He78)D200-20160331},
pnm = {314 - Immunologie und Krebs (POF4-314)},
pid = {G:(DE-HGF)POF4-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40556393},
doi = {DOI:10.3760/cma.j.cn112139-20250328-00164},
url = {https://inrepo02.dkfz.de/record/302272},
}